FDA Initiates Approval of Leucovorin Calcium for Cerebral Folate Deficiency

Summary

The FDA has initiated the approval of leucovorin calcium tablets for patients with cerebral folate deficiency (CFD), a neurological condition that impairs folate transport into the brain. While the article's title suggests the treatment is for autism symptoms, the actual content focuses on CFD, which can co-occur with autism spectrum disorder. The treatment addresses the underlying folate deficiency rather than autism symptoms directly.